Evolution of protease and reverse transcriptase inhibitor resistance-associated mutations in HIV-1-infected protease inhibitor-treated patients with persistent low viraemia

被引:0
作者
Duval, X [1 ]
Descamps, D
Breton, G
Darmon, S
Ecobichon, JL
Delarue, S
Peytavin, G
Leport, C
Vildé, JL
Brun-Vézinet, F
机构
[1] Hop Bichat Claude Bernard, Serv Malad Infect, F-75877 Paris, France
[2] Hop Bichat Claude Bernard, INSERM, E 0357, F-75877 Paris, France
[3] Hop Bichat Claude Bernard, Serv Virol, F-75877 Paris, France
[4] Hop Bichat Claude Bernard, Serv Pharmacol Clin, F-75877 Paris, France
关键词
D O I
暂无
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
引用
收藏
页码:197 / 199
页数:3
相关论文
共 5 条
  • [1] Clinical and immunologic outcome in patients with human immunodeficiency virus infection, according to virologic efficacy in the year after virus undetectability, during antiretroviral therapy
    Abgrall, S
    Duval, X
    Joly, V
    Descamps, D
    Matheron, S
    Costagliola, D
    [J]. CLINICAL INFECTIOUS DISEASES, 2003, 37 (11) : 1517 - 1526
  • [2] Drug resistance at low viraemia in HIV-1-infected patients with antiretroviral combination therapy
    Aleman, S
    Söderbärg, K
    Visco-Comandini, U
    Sitbon, G
    Sönnerborg, A
    [J]. AIDS, 2002, 16 (07) : 1039 - 1044
  • [3] Durable HIV treatment benefit despite low-level viremia - Reassessing definitions of success or failure
    Deeks, SG
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 286 (02): : 224 - 226
  • [4] Immunologic and virologic evolution during periods of intermittent and persistent low-level viremia
    Karlsson, AC
    Younger, SR
    Martin, JN
    Grossman, Z
    Sinclair, E
    Hunt, PW
    Hagos, E
    Nixon, DF
    Deeks, SG
    [J]. AIDS, 2004, 18 (07) : 981 - 989
  • [5] Genotypic resistance in HIV-1 - Infected patients with persistently detectable low-level viremia while receiving highly active antiretroviral therapy
    Nettles, RE
    Kieffer, TL
    Simmons, RP
    Cofrancesco, J
    Moore, RD
    Gallant, JE
    Persaud, D
    Siliciano, RF
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 (07) : 1030 - 1037